Baker McKenzie advised Xbrane Biopharma on the deal.Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Maha Kanaan
…
This content is for Standard 1 Year members only. LoginJoin Now